105 related articles for article (PubMed ID: 15150600)
1. Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis.
Wang W; Yang LY; Huang GW; Lu WQ; Yang ZL; Yang JQ; Liu HL
Br J Cancer; 2004 Jun; 90(12):2349-55. PubMed ID: 15150600
[TBL] [Abstract][Full Text] [Related]
2. ARAP1 negatively regulates stress fibers formation and metastasis in lung adenocarcinoma via controlling Rho signaling.
Zhang Z; Xie W; Gong B; Liang X; Yu H; Yu Y; Dong Z; Shao F
Discov Oncol; 2023 Nov; 14(1):214. PubMed ID: 38008882
[TBL] [Abstract][Full Text] [Related]
3. Association of tumor morphology with long-term prognosis after liver resection for patients with a solitary huge hepatocellular carcinoma-a multicenter propensity score matching analysis.
Xu XF; Wu H; Li JD; Yao LQ; Huang B; Diao YK; Chen TH; Gu WM; Chen Z; Li J; Zhang YM; Wang H; Liang YJ; Zhou YH; Li C; Wang MD; Zhang CW; Pawlik TM; Lau WY; Shen F; Yang T
Hepatobiliary Surg Nutr; 2023 Jun; 12(3):314-327. PubMed ID: 37351131
[TBL] [Abstract][Full Text] [Related]
4. Piezo1 promoted hepatocellular carcinoma progression and EMT through activating TGF-β signaling by recruiting Rab5c.
Li YM; Xu C; Sun B; Zhong FJ; Cao M; Yang LY
Cancer Cell Int; 2022 Apr; 22(1):162. PubMed ID: 35461277
[TBL] [Abstract][Full Text] [Related]
5. NAD(P)HX epimerase downregulation promotes tumor progression through ROS/HIF-1α signaling in hepatocellular carcinoma.
Sun B; Yu L; Xu C; Li YM; Zhao YR; Cao MM; Yang LY
Cancer Sci; 2021 Jul; 112(7):2753-2769. PubMed ID: 33932069
[TBL] [Abstract][Full Text] [Related]
6. Leukemia-Associated Rho Guanine Nucleotide Exchange Factor and Ras Homolog Family Member C Play a Role in Glioblastoma Cell Invasion and Resistance.
Ding Z; Dong Z; Yang Y; Fortin Ensign SP; Sabit H; Nakada M; Ruggieri R; Kloss JM; Symons M; Tran NL; Loftus JC
Am J Pathol; 2020 Oct; 190(10):2165-2176. PubMed ID: 32693062
[TBL] [Abstract][Full Text] [Related]
7. Expression And Biological Interaction Network Of RHOC For Hepatic Carcinoma With Metastasis In PBMC Samples.
Shen Y; Bu L; Li R; Chen Z; Tian F; Ge Q
Onco Targets Ther; 2019; 12():9117-9128. PubMed ID: 31806997
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of Pin1 and rho signaling partners correlates with metastatic behavior and poor recurrence-free survival of hepatocellular carcinoma patients.
Ng L; Kwan V; Chow A; Yau TC; Poon RT; Pang R; Law WL
BMC Cancer; 2019 Jul; 19(1):713. PubMed ID: 31324164
[TBL] [Abstract][Full Text] [Related]
9. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
[TBL] [Abstract][Full Text] [Related]
10. Anti-RhoC siRNAs inhibit the proliferation and invasiveness of breast cancer cells via modulating the KAI1, MMP9, and CXCR4 expression.
Xu XD; Shen HB; Zhu L; Lu JQ; Zhang L; Luo ZY; Wu YQ
Onco Targets Ther; 2017; 10():1827-1834. PubMed ID: 28367066
[TBL] [Abstract][Full Text] [Related]
11. YMO1 suppresses invasion and metastasis by inhibiting RhoC signaling and predicts favorable prognosis in hepatocellular carcinoma.
Chang RM; Pei L; Fang F; Xu JF; Yang H; Zuo CH; Zhou JH; Luo GQ; Yang LY
Oncotarget; 2016 Aug; 7(34):55585-55600. PubMed ID: 27487132
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1α signaling.
Chang RM; Xu JF; Fang F; Yang H; Yang LY
Tumour Biol; 2016 Aug; 37(8):10609-19. PubMed ID: 26861561
[TBL] [Abstract][Full Text] [Related]
13. Actin-like 6A predicts poor prognosis of hepatocellular carcinoma and promotes metastasis and epithelial-mesenchymal transition.
Xiao S; Chang RM; Yang MY; Lei X; Liu X; Gao WB; Xiao JL; Yang LY
Hepatology; 2016 Apr; 63(4):1256-71. PubMed ID: 26698646
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-372 inhibits endometrial carcinoma development by targeting the expression of the Ras homolog gene family member C (RhoC).
Liu BL; Sun KX; Zong ZH; Chen S; Zhao Y
Oncotarget; 2016 Feb; 7(6):6649-64. PubMed ID: 26673619
[TBL] [Abstract][Full Text] [Related]
15. Severely Impaired and Dysregulated Cytochrome P450 Expression and Activities in Hepatocellular Carcinoma: Implications for Personalized Treatment in Patients.
Yan T; Lu L; Xie C; Chen J; Peng X; Zhu L; Wang Y; Li Q; Shi J; Zhou F; Hu M; Liu Z
Mol Cancer Ther; 2015 Dec; 14(12):2874-86. PubMed ID: 26516155
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-424 inhibits Akt3/E2F3 axis and tumor growth in hepatocellular carcinoma.
Yang H; Zheng W; Shuai X; Chang RM; Yu L; Fang F; Yang LY
Oncotarget; 2015 Sep; 6(29):27736-50. PubMed ID: 26315541
[TBL] [Abstract][Full Text] [Related]
17. Effects of Ras homolog gene family, member C gene silencing combined with rapamycin on hepatocellular carcinoma cell growth.
Xie SL; Zhu MG; Chen GF; Wang GY; Lv GY
Mol Med Rep; 2015 Oct; 12(4):5077-85. PubMed ID: 26165487
[TBL] [Abstract][Full Text] [Related]
18. RhoC upregulation is correlated with reduced E-cadherin in human breast cancer specimens after chemotherapy and in human breast cancer MCF-7 cells.
Kawata H; Kamiakito T; Omoto Y; Miyazaki C; Hozumi Y; Tanaka A
Horm Cancer; 2014 Dec; 5(6):414-23. PubMed ID: 25123151
[TBL] [Abstract][Full Text] [Related]
19. Rho GTPases modulate malignant transformation of tumor cells.
Orgaz JL; Herraiz C; Sanz-Moreno V
Small GTPases; 2014; 5():e29019. PubMed ID: 25036871
[TBL] [Abstract][Full Text] [Related]
20. Up-regulated MicroRNA-181a induces carcinogenesis in hepatitis B virus-related hepatocellular carcinoma by targeting E2F5.
Zou C; Li Y; Cao Y; Zhang J; Jiang J; Sheng Y; Wang S; Huang A; Tang H
BMC Cancer; 2014 Feb; 14():97. PubMed ID: 24529171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
